Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

As a result of the stop work order, Vaxart said it had been forced to lay off 10% of its workforce. The company entered the ...

Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we ...

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine ...

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...

The R.I. Life Science Hub is leading development of our state’s first life science incubator, and is already generating a great return on our investment, writes House Speaker K. Joseph Shekarchi ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

Investor interest in the biotechnology industry hit a fever pitch in 2021 around the time Moderna launched Spikevax, its ...